Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT00961038 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Ciprofloxacin (PulmoSphere, BAYQ3939)
DRUG: Ciprofloxacin (PulmoSphere, BAYQ3939)
DRUG: Placebo

Sponsor

Bayer

Collaborators

[object Object]